comprehensive -WSS

comprehensive

author：Wikipedia 2025-08-23 08:52:37 - browse：3653

Alex Hogan/STAT

SAN FRANCISCO — It seemed like there was a point during last year’s J.P. Morgan Healthcare Conference when we all collectively realized, “Oh, 2023 is going to be another slog.” Indeed, a downturn has weighed on the biotech industry for nearly three years.

But this January, things feel different. Maybe it’s the abundance of sunlight that filled San Francisco this week. More likely, it’s the surge of deals that came in December. Whatever the reason, sentiment around Union Square in recent days was markedly more positive this year.

Most everyone I spoke to this week noticed the change in tenor. “I’m feeling a lot of good energy, honestly,” Mira Chaurushiya, senior partner at VC Westlake Village BioPartners, told me Tuesday. “It’s not only what happened the last few weeks of the year, but what people are projecting moving forward.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： European officials brace for rough respiratory virus season

WSS

Setback for rare diseases as Taysha Gene Therapies pulls back

The story of mRNA: From a loose idea to a tool that may help curb Covid

2023 Nobel Prize in Medicine goes to Karikó and Weissman

The United States is paying nearly triple for new Covid vaccines

Health insurers' Q3 question: how much care are people getting?

Do masks work? RCTs can't tell us

entertainment

comprehensive

focus

Affirmative action in medical school literally saved lives

The battle over the Brookhaven Landfill on Long Island

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

Affirmative action in medical school literally saved lives

IVG is promising — but it won’t replace IVF quite yet

Activists slam private health insurers over coverage restrictions

Do masks work? RCTs can't tell us

Guidelines to prevent youth baseball injuries need more muscle

What we owe ALS patients — and why one company fell short

leisure time

What we owe ALS patients — and why one company fell short

Do masks work? RCTs can't tell us

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

Why we need to separate burnout from moral injury in health care

Colonoscopy at 40? Study finds a possible benefit

Study points to new risk in gene therapy death of Terry Horgan

focus

knowledge

knowledge

focus